Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with lung cancer, confirmed by tissue or fluid testing, or — if that type of testing is not available — confirmed through at least two different imaging scans reviewed by a specialist medical team.
- People whose cancer staging, based on a PET-CT scan, falls within early to mid-stage lung cancer (stages IA to IIB, using the AJCC eighth edition classification).
- People aged 18 years or older.
- People who score 60 or above on the Karnofsky Performance Scale, which is a measure of general health and ability to carry out daily activities (confirm with trial site).
- People whose treating doctor has determined that surgery is not a suitable option, or who have chosen not to have surgery.
- People whose blood counts meet the required levels: white blood cells at or above 3×10⁹/L, platelets at or above 80×10⁹/L, and haemoglobin at or above 90g/L.
- People whose liver function results (total bilirubin, AST, and ALT) are no more than twice the upper limit of normal.
- People whose kidney function results meet the required levels: creatinine clearance at or above 60ml/min, or creatinine no more than 1.5 times the upper limit of normal.
- People who are willing and able to attend scheduled visits, follow the treatment plan, and complete all required tests and procedures, and who have signed a consent form.
Who may not be able to join:
- People who have, or have had, another type of cancer.
- People with poorly controlled heart failure or breathing failure, or whose heart or lung function is rated at grade 3 or below (confirm with trial site).
- People whose blood or organ function test results do not meet the required levels before joining the trial.
- People who are unlikely to be able to attend regular follow-up appointments due to personal, social, family, or location-related reasons.
- People who are pregnant (based on a positive pregnancy test) or who are currently breastfeeding.
- People who the investigating medical team considers unsuitable for the trial for other reasons.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Taize Yuan, Doctor, Guangzhou Concord Cancer Center,Guangzhou, Guangdong
Phone: 8620-32506160
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progression-free Survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.